About 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine
4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine (PubChem CID 54563479) has the molecular formula C47H93N13O
and a molecular weight of 856.35 g/mol. Its IUPAC name is 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine.
Molecular Properties
| Compound Name | 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine |
| PubChem CID | 54563479 |
| Molecular Formula | C47H93N13O |
| Molecular Weight | 856.35 g/mol |
| Exact Mass | 855.76 |
| IUPAC Name | 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine |
| SMILES | CCCCN1C(N2CCCCC2)(N2CCCC2)C(N2CCOCC2)NC(N2CCN(C(C)C)CC2)(N2CCN(C(C)CC)CC2)C1(N1CCN(C)CC1)N1CCN(CC)CC1 |
| InChI | InChI=1S/C47H93N13O/c1-8-11-21-60-45(55-19-15-16-20-55,54-17-13-12-14-18-54)44(53-38-40-61-41-39-53)48-46(56-34-26-51(27-35-56)42(4)5,57-36-28-52(29-37-57)43(6)9-2)47(60,58-30-22-49(7)23-31-58)59-32-24-50(10-3)25-33-59/h42-44,48H,8-41H2,1-7H3 |
| InChIKey | UJPQKIWVZYEVJG-UHFFFAOYSA-N |
| XLogP | 2.22 |
| TPSA | 60.14 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 61 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 856.35 |
| LogP ≤ 5 | 2.22 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 14 |
Analyze 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine?
The IUPAC name of 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine (CID 54563479) is 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine.
What is the SMILES notation for 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine?
The canonical SMILES for 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine is CCCCN1C(N2CCCCC2)(N2CCCC2)C(N2CCOCC2)NC(N2CCN(C(C)C)CC2)(N2CCN(C(C)CC)CC2)C1(N1CCN(C)CC1)N1CCN(CC)CC1.
What is the InChIKey of 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine?
The InChIKey is UJPQKIWVZYEVJG-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H93N13O/c1-8-11-21-60-45(55-19-15-16-20-55,54-17-13-12-14-18-54)44(53-38-40-61-41-39-53)48-46(56-34-26-51(27-35-56)42(4)5,57-36-28-52(29-37-57)43(6)9-2)47(60,58-30-22-49(7)23-31-58)59-32-24-50(10-3)25-33-59/h42-44,48H,8-41H2,1-7H3.
What are the key properties of 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine?
4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine has a molecular weight of 856.35 g/mol, XLogP of 2.22, 14 rotatable bonds, 1 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[6-(4-butan-2-ylpiperazin-1-yl)-4-butyl-5-(4-ethylpiperazin-1-yl)-5-(4-methylpiperazin-1-yl)-3-piperidin-1-yl-6-(4-propan-2-ylpiperazin-1-yl)-3-pyrrolidin-1-ylpiperazin-2-yl]morpholine is sourced from PubChem (CID 54563479), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).